Characteristics and risk factors of prolonged viable virus shedding in immunocompromised patients with COVID-19: a prospective cohort study
- 20 January 2023
- journal article
- letter
- Published by Elsevier in Journal of Infection
- Vol. 86 (4) , 412-414
Abstract
No abstract availableKeywords
Funding Information
- Korea National Institute of Health (2022-ER1609-00, 2022-NI-043-00, 6634-325-210)
This publication has 8 references indexed in Scilit:
- Clinical scoring system to predict viable viral shedding in patients with COVID-19Journal of Clinical Virology, 2022
- SARS-CoV-2 in immunocompromised individualsImmunity, 2022
- Comparison of outward transmission potential between vaccinated and partially vaccinated or unvaccinated individuals with the SARS-CoV-2 delta variant infectionJournal of Infection, 2022
- Incidence, Clinical Presentation, Relapses and Outcome of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Patients Treated With Anti-CD20 Monoclonal AntibodiesClinical Infectious Diseases, 2021
- Long-Term Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectiousness Among Three Immunocompromised Patients: From Prolonged Viral Shedding to SARS-CoV-2 SuperinfectionThe Journal of Infectious Diseases, 2021
- Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)Nature Communications, 2021
- Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for CancerNew England Journal of Medicine, 2020
- The duration of infectiousness of individuals infected with SARS-CoV-2Journal of Infection, 2020